Question 1

What are the potential benefits and risks of using Firmagon® for my condition?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Effectiveness and Safety of Firmagon® in Androgen Ablative Therapy of Advanced Hormone-dependent Prostate Carcinoma in Argentina clinical trial (NCT01861236). Contact the study team or your healthcare provider for specific answers.

Question 2

How does the monthly injection work compared to other treatments I might consider?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Effectiveness and Safety of Firmagon® in Androgen Ablative Therapy of Advanced Hormone-dependent Prostate Carcinoma in Argentina clinical trial (NCT01861236). Contact the study team or your healthcare provider for specific answers.

Question 3

What should I expect during the treatment process?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Effectiveness and Safety of Firmagon® in Androgen Ablative Therapy of Advanced Hormone-dependent Prostate Carcinoma in Argentina clinical trial (NCT01861236). Contact the study team or your healthcare provider for specific answers.

Question 4

Are there any specific side effects I should be aware of?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Effectiveness and Safety of Firmagon® in Androgen Ablative Therapy of Advanced Hormone-dependent Prostate Carcinoma in Argentina clinical trial (NCT01861236). Contact the study team or your healthcare provider for specific answers.

Question 5

How will my progress be monitored during the study?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Effectiveness and Safety of Firmagon® in Androgen Ablative Therapy of Advanced Hormone-dependent Prostate Carcinoma in Argentina clinical trial (NCT01861236). Contact the study team or your healthcare provider for specific answers.

Question 6

Is there any additional support available while participating in this trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Effectiveness and Safety of Firmagon® in Androgen Ablative Therapy of Advanced Hormone-dependent Prostate Carcinoma in Argentina clinical trial (NCT01861236). Contact the study team or your healthcare provider for specific answers.

What this study is about